-

Wu Yan1, Wang Jianhong1,2, Jiang Wen1

  • 1Department of Neurology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People's Republic of China.

概括

这项研究证实铁亡和亡途径是导致多发性硬化症 (MS) 风险的原因. 关键蛋白质如IFNA4和TNFAIP3,以及调节剂如APOE,被确定为MS的潜在治疗标.